about
Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled TrialsUnmet needs of patients with narcolepsy: perspectives on emerging treatment optionsCysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association StudiesObesity: An Immunometabolic PerspectiveMolecular factors in migraineOrexin signaling regulates both the hippocampal clock and the circadian oscillation of Alzheimer's disease-risk genesGenome-wide association analyses of sleep disturbance traits identify new loci and highlight shared genetics with neuropsychiatric and metabolic traitsBi-allelic and tri-allelic 5-HTTLPR polymorphisms and triptan non-response in cluster headache.Orexin receptors exert a neuroprotective effect in Alzheimer's disease (AD) via heterodimerization with GPR103Associations between the orexin (hypocretin) receptor 2 gene polymorphism Val308Ile and nicotine dependence in genome-wide and subsequent association studiesCrucial role of the orexin-B C-terminus in the induction of OX1 receptor-mediated apoptosis: analysis by alanine scanning, molecular modelling and site-directed mutagenesis.Opportunities and perspectives for developing orexin receptor antagonists.Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics.Acute Heat Stress Alters the Expression of Orexin System in Quail Muscle.Orexin and Central Modulation of Cardiovascular and Respiratory Function.Differential contribution of orexin receptors within the ventral tegmental area to modulation of persistent inflammatory pain.
P2860
Q26796379-E6357AB3-CD6A-4FB5-84BD-81EE6AC6DDFDQ26827736-5CBA662E-2BE3-4A9E-9DE5-D0DAFFDD2D9DQ28067073-BDA207FF-D5C2-4F7C-9BCA-C8C20D10F85EQ28072140-5CA108A3-BEFC-496E-A66A-6D2FA5858039Q28078828-6AC17C6D-5D75-4891-B2D9-C69651776724Q28315261-E6EFA67F-FE6D-4E41-A992-6D1B7DC50EDEQ33855009-07713367-3A4D-4EAF-8EA8-E3EF1017C9D0Q33957309-A1526130-7FA6-4A0B-8AB6-C05996FF3222Q35902193-8A51B24D-9238-4F3F-A3C1-24E61B013120Q35986450-5A894214-7541-44AA-8037-A7E16A6D1285Q36394992-E82DBA2C-512A-41A0-961F-B3A87A9D8708Q40609526-5D22A4A9-4B80-4F46-9845-DE9ACDEC2BF2Q44349574-886D3612-4057-4345-9998-1695B2BBFA88Q47194591-00456C74-5030-44BF-BE95-6A87C62AF673Q47357997-E6568C60-72A5-4FB7-92EB-53FE6D70A147Q48911095-632E2386-2172-462E-BB5D-6BE9502CAE07
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
OX1 and OX2 orexin/hypocretin receptor pharmacogenetics
@ast
OX1 and OX2 orexin/hypocretin receptor pharmacogenetics
@en
OX1 and OX2 orexin/hypocretin receptor pharmacogenetics
@nl
type
label
OX1 and OX2 orexin/hypocretin receptor pharmacogenetics
@ast
OX1 and OX2 orexin/hypocretin receptor pharmacogenetics
@en
OX1 and OX2 orexin/hypocretin receptor pharmacogenetics
@nl
prefLabel
OX1 and OX2 orexin/hypocretin receptor pharmacogenetics
@ast
OX1 and OX2 orexin/hypocretin receptor pharmacogenetics
@en
OX1 and OX2 orexin/hypocretin receptor pharmacogenetics
@nl
P2093
P2860
P3181
P356
P1476
OX1 and OX2 orexin/hypocretin receptor pharmacogenetics
@en
P2093
Henri Xhaard
Innocenzo Rainero
Jyrki P. Kukkonen
Miles D. Thompson
Takeshi Sakurai
P2860
P3181
P356
10.3389/FNINS.2014.00057
P407
P577
2014-01-01T00:00:00Z